Todd Franklin Watanabe owns 0.76% of Arcutis Biotherapeutics
950,337 shares as of the August 3, 2026 filing, worth $27.4M at the latest close.
ARQT · $3.6B market capGet an email when Todd Franklin Watanabe’s stake moves.
Free.
The stake
0.76%
worth $27.4M at the latest close
Stake rank
#1,043
by dollar value of the stake
Last sale
77 days ago
Aug 3, 2026
Last buy
688 days ago
Nov 30, 2024 · $21,250
Todd Franklin Watanabe owns 0.76% of Arcutis Biotherapeutics, Inc.: 950,337 of 125,691,961 shares, worth about $27.4M at the 2026-10-16 close. The stake has moved from 1.41% in 2020 to 0.76% on 2026-08-03, across 44 sales and 2 purchases that moved it since 2016. The last trade that moved it was a planned sale of $114,261 on 2026-08-03.
How the stake is held
as of the Aug 3, 2026 filing
SHARES
OF THE STAKE
COMMON STOCK · stated Aug 3, 2026 · Form 4 ↗
HELD DIRECTLY
717,203
75.5%
HELD INDIRECTLY · 2 VEHICLES
233,134
24.5%
By Trust
175,776
18.5%
By LLC
57,358
6.0%
THE STAKE
950,337
0.76%